Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently developing a best-in-class peptides experience, including U. S.
Source: [The Hill](https://thehill.com/policy/healthcare/6023657-hims-hers-plans-compounded-peptides/)